Sin3B Expression Is Required for Cellular Senescence and Is Up-regulated upon Oncogenic Stress

被引:46
作者
Grandinetti, Kathryn B. [1 ]
Jelinic, Petar [1 ]
DiMauro, Teresa [1 ]
Pellegrino, Jessica [1 ]
Rodriguez, Ruben Fernandez [1 ]
Finnerty, Patricia M. [1 ]
Ruoff, Rachel [1 ,2 ,3 ]
Bardeesy, Nabeel [4 ]
Logan, Susan K. [1 ,2 ,3 ]
David, Gregory [1 ,3 ]
机构
[1] NYU, Dept Pharmacol, Langone Med Ctr, New York, NY 10016 USA
[2] NYU, Dept Urol, Langone Med Ctr, New York, NY 10016 USA
[3] NYU, Inst Canc, Langone Med Ctr, New York, NY 10016 USA
[4] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA
关键词
TUMOR-SUPPRESSOR; DNA-DAMAGE; HETEROCHROMATIN FORMATION; E2F; P53; TARGETS; P16(INK4A); SUFFICIENT; CONTRIBUTE; COMPLEXES;
D O I
10.1158/0008-5472.CAN-09-0537
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Serial passage of primary mammalian cells or strong mitogenic signals induce a permanent exit from the cell cycle called senescence. A characteristic of senescent cells is the hetero-chromatinization of loci encoding pro-proliferative genes, leading to their transcriptional silencing. Senescence is thought to represent a defense mechanism against uncontrolled proliferation and cancer. Consequently, genetic alterations that allow senescence bypass are associated with susceptibility to oncogenic transformation. We show that fibroblasts genetically inactivated for the chromatin-associated Sin3B protein are refractory to replicative and oncogene-induced senescence. Conversely, overexpression of Sin3B triggers senescence and the formation of senescence-associated heterochromatic foci. Although Sin3B is strongly up-regulated upon oncogenic stress, decrease in expression of Sin3B is associated with tumor progression in vivo, suggesting that expression of Sin3B may represent a barrier against transformation. Together, these results underscore the contribution of senescence in tumor suppression and suggest that expression of chromatin modifiers is modulated at specific stages of cellular transformation. Consequently, these findings suggest that modulation of Sin3B-associated activities may represent new therapeutic opportunities for treatment of cancers. [Cancer Res 2009;(69(16):6430-7]
引用
收藏
页码:6430 / 6437
页数:8
相关论文
共 42 条
[1]   Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics [J].
Aslanian, A ;
Iaquinta, PJ ;
Verona, R ;
Lees, JA .
GENES & DEVELOPMENT, 2004, 18 (12) :1413-1422
[2]   Pocket protein complexes are recruited to distinct targets in quiescent and proliferating cells [J].
Balciunaite, E ;
Spektor, A ;
Lents, NH ;
Cam, H ;
Riele, HT ;
Scime, A ;
Rudnicki, MA ;
Young, R ;
Dynlacht, BD .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (18) :8166-8178
[3]   Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints [J].
Bartkova, Jirina ;
Rezaei, Nousin ;
Liontos, Michalis ;
Karakaidos, Panagiotis ;
Kletsas, Dimitris ;
Issaeva, Natalia ;
Vassiliou, Leandros-Vassilios F. ;
Kolettas, Evangelos ;
Niforou, Katerina ;
Zoumpourlis, Vassilis C. ;
Takaoka, Munenori ;
Nakagawa, Hiroshi ;
Tort, Frederic ;
Fugger, Kasper ;
Johansson, Fredrik ;
Sehested, Maxwell ;
Andersen, Claus L. ;
Dyrskjot, Lars ;
Orntoft, Torben ;
Lukas, Jiri ;
Kittas, Christos ;
Helleday, Thomas ;
Halazonetis, Thanos D. ;
Bartek, Jiri ;
Gorgoulis, Vassilis G. .
NATURE, 2006, 444 (7119) :633-637
[4]   Hitting their targets: an emerging picture of E2F and cell cycle control [J].
Blais, A ;
Dynlacht, BD .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2004, 14 (05) :527-532
[5]   c-Myc target gene specificity is determined by a post-DNA-binding mechanism [J].
Boyd, KE ;
Wells, J ;
Gutman, J ;
Bartley, SM ;
Farnham, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (23) :13887-13892
[6]   Oncogene-induced senescence as an initial barrier in lymphoma development [J].
Braig, M ;
Lee, S ;
Loddenkemper, C ;
Rudolph, C ;
Peters, AHFM ;
Schlegelberger, B ;
Stein, H ;
Dörken, B ;
Jenuwein, T ;
Schmitt, CA .
NATURE, 2005, 436 (7051) :660-665
[7]   Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis [J].
Chen, ZB ;
Trotman, LC ;
Shaffer, D ;
Lin, HK ;
Dotan, ZA ;
Niki, M ;
Koutcher, JA ;
Scher, HI ;
Ludwig, T ;
Gerald, W ;
Cordon-Cardo, C ;
Pandolfi, PP .
NATURE, 2005, 436 (7051) :725-730
[8]   The pathological response to DNA damage does not contribute to p53-mediated tumour suppression [J].
Christophorou, M. A. ;
Ringshausen, I. ;
Finch, A. J. ;
Swigart, L. Brown ;
Evan, G. I. .
NATURE, 2006, 443 (7108) :214-217
[9]   Tumour biology -: Senescence in premalignant tumours [J].
Collado, M ;
Gil, J ;
Efeyan, A ;
Guerra, C ;
Schuhmacher, AJ ;
Barradas, M ;
Benguría, A ;
Zaballos, A ;
Flores, JM ;
Barbacid, M ;
Beach, D ;
Serrano, M .
NATURE, 2005, 436 (7051) :642-642
[10]   Cellular senescence in cancer and aging [J].
Collado, Manuel ;
Blasco, Maria A. ;
Serrano, Manuel .
CELL, 2007, 130 (02) :223-233